News & Press

Placebo Response Mitigation in Pain Clinical Trials

Placebo Response Mitigation in Pain Clinical Trials - LinkedIn Post

If you are attending the Pain Therapeutics Summit in San Diego then do not miss this exciting Pre-Conference workshop held by Neil Singla, MD, Chief Scientific Officer, Lotus Clinical Research, LLC . “Placebo Response Mitigation in Pain Clinical Trials” promises to be an insightful session as Dr. Singla, a board-certified anesthesiologist shares his findings in response mitigation strategy he has deployed in over 50 analgesic clinical trials.
For more information about the workshop visit Pain Conference 2023 – Annual Pain Therapeutics Summit Workshop (paintherapeuticsummit.com)

For more information about Dr. Singla and the Lotus Clinical Research team visit: Lotus Clinical Research | A Specialty CNS CRO (lotuscr.com)

To learn more about Evolution Research Group (ERG) and our capabilities visit: ERG | Trusted clinical research site company (ergclinical.com)